Join

Compare · EYES vs SNN

EYES vs SNN

Side-by-side comparison of Second Sight Medical Products Inc. (EYES) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EYES and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
  • SNN is the larger of the two at $14.70B, about 282.5x EYES ($52.0M).
  • SNN has hit the wire 6 times in the past 4 weeks while EYES has been quiet.
  • SNN has more recent analyst coverage (22 ratings vs 0 for EYES).
MetricEYESSNN
Company
Second Sight Medical Products Inc.
Smith & Nephew SNATS Inc.
Price
$4.16-4.59%
$31.57-1.16%
Market cap
$52.0M
$14.70B
1M return
-
-2.70%
1Y return
-
+18.02%
Industry
Industrial Specialties
Industrial Specialties
Exchange
NASDAQ
NYSE
IPO
2014
News (4w)
0
6
Recent ratings
0
22
EYES

Second Sight Medical Products Inc.

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

SNN

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.